Company-wide revenue
Reported revenue in 2020 ¥1.12B Reported revenue in 2024 ¥1.46B
- growth amount
- +¥330.94M
- growth annualized
- +6.7%
- growth total
- +29.4%
Japanese company profile · 6090
Human Metabolome Technologies, Inc.
In its FY2024 public filing, Human Metabolome Technologies, Inc. reports Advanced Research and Development Support Scheme, Healthcare Solutions. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: ヒューマン・メタボローム・テクノロジーズ株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Human Metabolome Technologies, Inc.'s largest reported business by revenue in FY2024 was Advanced Research and Development Support Scheme.
The business with the highest reported segment profit in FY2024 was Advanced Research and Development Support Scheme.
FY2024 · fiscal year ended June 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Advanced Research and Development Support Scheme | ¥1.14B ↗ | 78.6% | ¥184.59M ↗ |
| Healthcare Solutions | ¥312M ↗ | 21.4% | ¥64.94M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2024 · fiscal year ended June 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Advanced Research and Development Support Scheme
- 先端研究開発支援事業
- Healthcare Solutions
- ヘルスケア・ソリューション事業
- Business label unavailable in English
- メタボロミクス事業
- Business label unavailable in English
- バイオマーカー事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Advanced Research and Development Support Scheme
- 先端研究開発支援事業
- Healthcare Solutions
- ヘルスケア・ソリューション事業
- Business label unavailable in English
- メタボロミクス事業
- Business label unavailable in English
- バイオマーカー事業
- Sales
- 売上高
- Operating profit
- 営業利益
What is growing?
What is growing?
Business revenue growth
Healthcare Solutions
Reported revenue in 2021 ¥2.86M Reported revenue in 2024 ¥312M
- growth amount
- +¥309.14M
- growth annualized
- +378.0%
- growth total
- +10,824.3%
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2024 · fiscal year ended June 2025
The source document may be in Japanese.
Filing ID: S100WPSX
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.